Evidence map›Paper›PMID 42145713›Full record

ArticleFrontiers in medicine2026

Early removal of post-operative scabs after follicular unit extraction using a 2% salicylic acid keratolytic shampoo: a multicentre descriptive pilot study.

Teresa Meyer, Pablo Fernández-González, Alia Shafiq-Sánchez, Alba Gómez-Zubiaur

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Teresa MeyerMeyer & Alcaide, Centro Sanitario de la Piel y el Pelo, Málaga, Spain.
Pablo Fernández-GonzálezMedical Affairs Department, Cantabria Labs, Madrid, Spain.
Alia Shafiq-SánchezMedical Affairs Department, Cantabria Labs, Madrid, Spain.
Alba Gómez-ZubiaurTrichology Unit, Instituto Médico Ricart, Madrid & Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hair transplantation is increasingly performed for advanced androgenetic alopecia (AGA), yet postoperative scalp care remains poorly standardized. Persistent scabs after follicular unit extraction (FUE) may delay healing, compromise graft survival, and increase the risk of infection. Objective: To evaluate the effectiveness and tolerability of a keratolytic shampoo containing 2% salicylic acid, piroctone olamine, and a micro-depositing conditioning polymer for the early management of postoperative scabs after FUE. Methods: A prospective, multicenter, single-arm pilot study was conducted in 21 male patients following a structured 10-day washing protocol starting 48-72 h post-surgery. Investigator-assessed erythema, desquamation, and scab scores were recorded, along with patient-reported symptoms and satisfaction. Results: Mean scab severity decreased from 2.67 ± 0.97 to 1.76 ± 0.62, indicating effective crust detachment without barrier disruption. Erythema increased transiently post-wash (1.90 ± 0.62 to 2.81 ± 1.21) but was not associated with burning, itching, or pain. The overall mean satisfaction score was 4.05 ± 0.77, with 76.2% of patients agreeing that the shampoo reduced scabs and 67% stating they would recommend it. No adverse events were recorded. Conclusion: Continuous use of this 2% salicylic acid-based keratolytic cleanser from 48-72 h after FUE promoted gentle scab removal, excellent tolerability, and high patient satisfaction. Incorporating such formulations into early postoperative care may improve outcomes and comfort after hair transplantation.

Indexed as

hair transplantationkeratolytic therapypost-operative scabssalicylic acid shampooscalp wound care

Identifiers

PMID42145713
PMCPMC13175871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.